For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Musculoskeletal disorders are the group of pain disorders or injuries that affect the body's joints, muscles, nerves, ligaments, tendons, and structures, all of which support the hands, legs, neck and back. The pain and discomfort vary with the severity of the condition. These disorders have a wide range of causes, but usually occur depending on the age, lifestyle, and occupation of an individual. Symptoms usually range from recurrent pain, stiffness, and swellings. X-rays and other medical imaging procedures may diagnose the condition. The treatment mainly depends on the severity of the condition. Apart from the drugs, physical therapy, and occupational therapy are also used to manage the condition.
Scope of the Report:
This report studies the Musculoskeletal Disorders Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Musculoskeletal Disorders Therapeutics market by product type and applications/end industries.
MSDs mostly occur because of the over-exhaustion of weak muscles, ligaments, or tendons. Also, vigorous vocational activities can lead to musculoskeletal pain. Uncured MSDs can result in chronic disruption of the mundane and vocational tasks of the patient. Some of the major therapeutics to treat MSDs include corticosteroids, biologics, parathyroid hormone, selective estrogen receptor modulators, protein therapy, synthetic bone graft, demineralized bone matrix, composite grafts, and BMPS, orthobiologics.
The global Musculoskeletal Disorders Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Musculoskeletal Disorders Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
- Pfizer
- AbbVie
- Johnson & Johnson
- Sanofi
- Merck
- Novartis
- Eli Lilly
- AstraZeneca
- Boehringer Ingelheim
- F. Hoffmann-La Roche
- Amgen
- Takeda Pharmaceutical
- Daiichi Sankyo
- LG Life Sciences
- Astellas
- Samsung Bioepis
- Zosano Pharma
- Taisho Pharmaceutical
- 3SBio
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Biologics
- Small Molecules
- Other
Market Segment by Applications, can be divided into
- Osteoarthritis
- Osteoporosis
- Psoriatic Arthritis
- Ankylosing Spondylitis
- Fibromyalgia
- Other